NEWRON PHARMACEUT. EO-20 (NP5) — Working Capital to Net Assets Ratio
NEWRON PHARMACEUT. EO-20 (NP5) has a Working Capital to Net Assets ratio of 1288.7% as of June 2025. Working capital of €20.39 Million (current assets of €60.47 Million minus current liabilities of €40.08 Million) is measured against net assets of €1.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See NP5 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
NEWRON PHARMACEUT. EO-20 Working Capital to Net Assets (2005–2024)
This chart shows how NEWRON PHARMACEUT. EO-20's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 1288.7%, reflecting working capital of €20.39 Million against net assets of €1.58 Million EUR. Check how tangible is NEWRON PHARMACEUT. EO-20's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for NEWRON PHARMACEUT. EO-20 (2005–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for NEWRON PHARMACEUT. EO-20 from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see NEWRON PHARMACEUT. EO-20 market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2578.7% | €37.60 Million | €1.46 Million | €61.10 Million | €23.51 Million | ▲ +2547.7 pp |
| 2023 | 31.0% | €-9.27 Million | €-29.91 Million | €19.65 Million | €28.93 Million | ▲ +198.2 pp |
| 2022 | -167.2% | €23.45 Million | €-14.03 Million | €28.49 Million | €5.04 Million | ▼ -1318.5 pp |
| 2021 | 1151.4% | €35.77 Million | €3.11 Million | €39.43 Million | €3.65 Million | ▲ +971.7 pp |
| 2020 | 179.6% | €30.98 Million | €17.25 Million | €37.87 Million | €6.89 Million | ▲ +71.2 pp |
| 2019 | 108.4% | €39.90 Million | €36.80 Million | €45.49 Million | €5.59 Million | ▲ +8.0 pp |
| 2018 | 100.4% | €55.08 Million | €54.84 Million | €59.51 Million | €4.43 Million | ▼ -0.1 pp |
| 2017 | 100.5% | €68.07 Million | €67.72 Million | €72.80 Million | €4.73 Million | ▲ +1.0 pp |
| 2016 | 99.5% | €49.49 Million | €49.75 Million | €56.14 Million | €6.64 Million | ▼ -1.4 pp |
| 2015 | 100.9% | €37.46 Million | €37.11 Million | €43.97 Million | €6.51 Million | ▲ +15.8 pp |
| 2014 | 85.1% | €24.90 Million | €29.26 Million | €29.39 Million | €4.49 Million | ▲ +10.5 pp |
| 2013 | 74.6% | €15.73 Million | €21.09 Million | €21.80 Million | €6.07 Million | ▼ -2.1 pp |
| 2012 | 76.7% | €21.16 Million | €27.61 Million | €32.75 Million | €11.59 Million | ▲ +3.7 pp |
| 2011 | 72.9% | €4.80 Million | €6.58 Million | €7.63 Million | €2.83 Million | ▲ +3.4 pp |
| 2010 | 69.5% | €8.47 Million | €12.19 Million | €13.11 Million | €4.63 Million | ▼ -9.3 pp |
| 2009 | 78.8% | €23.08 Million | €29.28 Million | €31.74 Million | €8.65 Million | ▼ -2.4 pp |
| 2008 | 81.3% | €37.23 Million | €45.81 Million | €47.24 Million | €10.01 Million | ▼ -22.8 pp |
| 2007 | 104.1% | €59.74 Million | €57.40 Million | €69.52 Million | €9.77 Million | ▼ -2.5 pp |
| 2006 | 106.6% | €72.34 Million | €67.86 Million | €85.13 Million | €12.79 Million | ▲ +11.7 pp |
| 2005 | 95.0% | €16.16 Million | €17.02 Million | €21.28 Million | €5.12 Million | — |